Business Context and Reporting Period
This Form 8-K Current Report was filed by Community Health Systems, Inc. on February 19, 2021, reporting events that occurred on February 16, 2021. The filing addresses changes in executive leadership and the approval of 2021 compensation arrangements for Named Executive Officers.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive appointments and compensation structures.
Material Changes
Executive Leadership Change
On February 16, 2021, the Board of Directors elected and appointed Kevin J. Hammons, previously Executive Vice President and Chief Financial Officer, to the position of President and Chief Financial Officer. No new compensatory plan or contract was entered into specifically for this appointment.
2021 Compensation Approvals
The Board approved the following compensation components for fiscal year 2021:
- Base Salaries:
- Wayne T. Smith (Executive Chairman): $1,000,000
- Tim L. Hingtgen (CEO): $1,200,000
- Kevin J. Hammons (President and CFO): $700,000
- Lynn T. Simon, M.D. (President of Clinical Operations and CMO): $625,000
- Benjamin C. Fordham (EVP, General Counsel): $625,000
- Cash Incentive Compensation: Target opportunities range from 115% to 225% of base salary, with potential additional awards for non-financial performance improvements and overachievement of company goals.
- Long-Term Equity Awards: Grants of Non-Qualified Stock Options, Time-Vesting Restricted Stock, and Performance-Based Restricted Stock were approved, effective March 1, 2021. Performance-based shares vest based on objectives from January 1, 2021, to December 31, 2023, with a vesting range of 0% to 200%.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on market conditions. It notes that performance-based equity awards are contingent on achieving specific performance objectives over a three-year period. No specific risks or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the exact vesting terms and performance metrics for the 2021 equity grants in the definitive proxy statement.
- Confirm the total potential payout for cash incentives given the variable nature of non-financial and overachievement bonuses.
- Review the Company's 2020 Proxy Statement (filed April 2, 2020) for detailed biographical information on Kevin J. Hammons as referenced in the filing.
- Monitor future filings for the actual payout of 2020 incentive compensation, which is scheduled to be disclosed in the 2021 annual meeting proxy statement.